RBC Capital analyst Arun Viswanathan downgraded Chemours to Sector Perform from Outperform with a price target of $33, down from $35. The analyst sees a downward estimate revision cycle persisting through the first half of 2023 due to weak TiO2 markets and tough compares. A potential settlement with the water districts and strong cash flow and balance sheet metrics "are possible upside risks" to the downgrade, Viswanathan tells investors in a research note.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CC: